ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,104, issued on March 31, was assigned to The Regents of the University of California (Oakland, Calif.) and UNIVERSITY COLLEGE DUBLIN (Dublin).
"Thiosaccharides for use in treating coronavirus infection" was invented by John Vincent Fahy (San Francisco), Irina Gitlin (San Francisco), Wilfred Raymond (San Francisco) and Stefan Oscarson (Dublin).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, inter alia, are methods of using thiosaccharide compounds for treating coronavirus infection."
The patent was filed on May 11, 2021, under Application No. 17/924,662.
*For further information, including images, charts and tables, please visit: h...